Robot surgeons target testicular cancer with fluorescent dye
NCT ID NCT06133543
Summary
This study is testing a new, minimally invasive diagnostic technique for men with early-stage testicular cancer. Doctors will use a robot and a fluorescent dye to find and remove the 'sentinel' lymph node, which is the first place cancer is likely to spread. The goal is to more accurately determine if the cancer has spread, which could help many patients avoid unnecessary chemotherapy or major surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Duesseldorf
RECRUITINGDüsseldorf, Germany
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.